CVS Group plc (LON:CVSG) Stock Has Consensus Target Price of GBX 1,666.67 According to Brokerages

Shares of CVS Group plc (LON:CVSG – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the six research firms that are presently covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is GBX 1,666.67.

CVSG has been the subject of a number of research analyst reports. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a GBX 1,700 target price on shares of CVS Group in a report on Monday, July 27th. Jefferies Financial Group reaffirmed a “hold” rating and issued a GBX 1,400 price target on shares of CVS Group in a research note on Friday, September 25th. Berenberg Bank reaffirmed a “buy” rating and issued a GBX 2,000 price target on shares of CVS Group in a research note on Thursday, September 24th. Finally, Shore Capital Group reiterated a “hold” rating and set a GBX 1,400 price target on shares of CVS Group in a research report on Thursday, September 24th.

Get Our Latest Stock Analysis on CVS Group

Insider Buying and Selling at CVS Group

In other CVS Group news, insider Robin Alfonso bought 768 shares of the stock in a transaction on Thursday, August 6th. The shares were bought at an average price of GBX 1,294 per share, with a total value of £9,937.92. Also, insider David Wilton bought 1,500 shares of the stock in a transaction on Tuesday, August 4th. The shares were acquired at an average cost of GBX 1,276 per share, for a total transaction of £19,140. In the last 90 days, insiders have bought 3,860 shares of company stock worth $4,956,696. Corporate insiders own 1.48% of the company’s stock.

CVS Group Trading Down 1.4%

Shares of CVS Group stock opened at GBX 1,304 on Monday. The firm has a market capitalization of £879.69 million, a PE ratio of 53.66, a P/E/G ratio of 1.77 and a beta of 1.09. CVS Group has a twelve month low of GBX 1,062 and a twelve month high of GBX 1,448. The firm’s 50-day moving average price is GBX 1,267.96 and its 200 day moving average price is GBX 1,232.95. The company has a current ratio of 1.18, a quick ratio of 0.90 and a debt-to-equity ratio of 110.41.

CVS Group (LON:CVSG – Get Free Report) last posted its quarterly earnings data on Thursday, September 24th. The company reported GBX 85.60 earnings per share (EPS) for the quarter. CVS Group had a return on equity of 5.91% and a net margin of 2.43%. On average, sell-side analysts predict that CVS Group will post 93.94 EPS for the current fiscal year.

About CVS Group

(Get Free Report)

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.

Recommended Stories

Analyst Recommendations for CVS Group (LON:CVSG)

Receive News & Ratings for CVS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group and related companies with MarketBeat.com's FREE daily email newsletter.